-inc-logo-1200x675.png){kind=logo}
WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report)’s share price reached a new 52-week high during trading on Tuesday . The stock traded as high as $13.15 and last traded at $13.03, with a volume of 1941 shares changing hands. The stock had previously closed at $12.91.
WuXi Biologics (Cayman) Price Performance
The stock has a 50-day simple moving average of $10.14 and a 200-day simple moving average of $9.35.
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.
The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.
Featured Stories
- Five stocks we like better than WuXi Biologics (Cayman)
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
